15,16-dihydrotanshinone i-induced apoptosis in human colorectal cancer cells: Involvement of ATF3

Anticancer Research

Volumn 33, Issue 8, 2013, Pages 3225-3232

  Suk, Fat Moon ^a   Jou, Wen Ju ^b   Lin, Ren Jye ^c   Lin, Shyr Yi ^c   Tzeng, Fang Yu ^d   Liang, Yu Chih ^c,d  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI CITY HOSPITAL   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

15,16 Dihydrotanshinone I; Activating transcription factor 3; Colorectal cancer; SW420 cells; SW480; SW620

Indexed keywords

15,16 DIHYDROTANSHINONE I; ACTIVATING TRANSCRIPTION FACTOR 3; PLANT MEDICINAL PRODUCT; UNCLASSIFIED DRUG;

ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CARCINOMA CELL; CELL PROLIFERATION; COLORECTAL CARCINOMA; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

15,16-DIHYDROTANSHINONE I; ACTIVATING TRANSCRIPTION FACTOR-3; COLORECTAL CANCER; SW420 CELLS; SW480; SW620;

ACTIVATING TRANSCRIPTION FACTOR 3; ADENOCARCINOMA; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; COLORECTAL NEOPLASMS; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASES; NEOPLASM METASTASIS; PHENANTHRENES; PHOSPHORYLATION;

EID: 84883268359     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Eheman C, Henley SJ, Ballard-Barbash R, Jacobs EJ, Schymura MJ, Noone AM, Pan L, Anderson RN, Fulton JE, Kohler BA, Jemal A, Ward E, Plescia M, Ries LA and Edwards BK: Annual Report to the Nation on the status of cancer, 1975-2008, featuring cancers associated with excess weight and lack of sufficient physical activity. Cancer 1189: 2338-2366, 2012.
2. Allan AL, Albanese C, Pestell RG and LaMarre J: Activating transcription factor 3. induces DNA synthesis and expression of cyclin D1 in hepatocytes. J Biol Chem 276: 27272-27280, 2001.
3. Liang G, Wolfgang CD, Chen BP, Chen TH and Hai T: ATF3 gene. Genomic organization, promoter, and regulation. J Biol Chem 271: 1695-1701, 1996.
4. Turchi L, Fareh M, Aberdam E, Kitajima S, Simpson F, Wicking C, Aberdam D and Virolle T: ATF3 and p15PAF are novel gatekeepers of genomic integrity upon UV stress. Cell Death Differ 16: 728-737, 2009.
5. Hsu JC, Laz T, Mohn KL and Taub R: Identification of LRF-1, a leucine-zipper protein that is rapidly and highly induced in regenerating liver. Proc Natl Acad Sci USA 88: 3511-3515, 1991.
6. Hai T and Hartman MG: The molecular biology and nomenclature of the activating transcription factor/cAMP responsive element-binding family of transcription factors: activating transcription factor proteins and homeostasis. Gene 273: 1-11, 2001.
7. Shtil AA, Mandlekar S, Yu R, Walter RJ, Hagen K, Tan TH, Roninson IB and Kong AN: Differential regulation of mitogenactivated protein kinases by microtubule-binding agents in human breast cancer cells. Oncogene 18: 377-384, 1999.
8. Nawa T, Nawa MT, Cai Y, Zhang C, Uchimura I, Narumi S, Numano F and Kitajima S: Repression of TNF-α-induced Eselectin expression by PPAR activators: involvement of transcriptional repressor LRF-1/ATF3. Biochem Biophys Res Commun 275: 406-411, 2000.
9. Francis JS, Dragunow M and During MJ: Overexpression of ATF3 protects rat hippocampal neurons from in vivo injection of kainic acid. Brain Res Mol Brain Res 124: 199-203, 2004.
10. Lu D, Wolfgang CD and Hai T: Activating transcription factor 3, a stress-inducible gene, suppresses Ras-stimulated tumorigenesis. J Biol Chem 281: 10473-10481, 2006.
11. Nobori K, Ito H, Tamamori-Adachi M, Adachi S, Ono Y, Kawauchi J, Kitajima S, Marumo F and Isobe M: ATF3 inhibits doxorubicin-induced apoptosis in cardiac myocytes: A novel cardioprotective role of ATF3. J Mol Cell Cardiol 34: 1387-1397, 2002.
12. Tzen JT, Jinn TR, Chen YC, Li FY, Cheng FC, Shi LS, She H, Chen BC, Hsieh V and Tu ML: Magnesium lithospermate B possesses inhibitory activity on Na+,K+-ATPase and neuroprotective effects against ischemic stroke. Acta Pharmacol Sin 28: 609-615, 2007.
13. Wang X, Morris-Natschke SL and Lee KH: New developments in the chemistry and biology of the bioactive constituents of Tanshen. Med Res Rev 27: 133-148, 2007.
14. Tsai SL, Suk FM, Wang CI, Liu DZ, Hou WC, Lin PJ, Hung LF and Liang YC: Antitumor potential of 15,16-dihydrotanshinone I against breast adenocarcinoma through inducing G 1 arrest and apoptosis. Biochem Pharmacol 74: 1575-1586, 2007.
15. Lee P, Hur J, Lee J, Kim J, Jeong J, Kang I, Kim SY and Kim H: 15,16-dihydrotanshinone I suppresses the activation of BV-2 cell, a murine microglia cell line, by lipopolysaccharide. Neurochem Int 48: 60-66, 2006.
16. Jeon SJ, Son KH, Kim YS, Choi YH and Kim HP: Inhibition of prostaglandin and nitric oxide production in lipopolysaccharidetreated RAW 264.7 cells by tanshinones from the roots of Salvia miltiorrhiza Bunge. Arch Pharmacal Res 31: 758-763, 2008.
17. Lee WY, Liu KW and Yeung JH: Reactive oxygen speciesmediated kinase activation by dihydrotanshinone in tanshinonesinduced apoptosis in HepG2 cells. Cancer Lett 285: 46-57, 2009.
18. Chuang MT, Ho FM, Wu CC, Zhuang SY, Lin SY, Suk FM and Liang YC: 15,16-Dihydrotanshinone I, a compound of Salvia miltiorrhiza Bunge, induces apoptosis through inducing endoplasmic reticular stress in human prostate carcinoma cells. Evid Based Complement Alternat Med 2011: 865435, 2011.
19. Liu DZ, Liang HJ, Chen CH, Lin SY, Zhong WB, Ho FM, Hou WC, Lo JL, Ho YS, Lin PJ, Hung LF and Liang YC: Switch activation of PI-PLC downstream signals in activated macrophages with wortmannin. Biochim Biophys Acta 17736: 869-879, 2007.
20. Raman M, Chen W and Cobb MH: Differential regulation and properties of MAPKs. Oncogene 26: 3100-3112, 2007.
21. Junttila MR, Li SP and Westermarck J: Phosphatase-mediated crosstalk between MAPK signaling pathways in the regulation of cell survival. FASEB J 224: 954-965, 2008.
22. Weston CR and Davis RJ: The JNK signal transduction pathway. Curr Opin Cell Biol 192: 142-149, 2007.
23. Lind DS, Hochwald SN, Malaty J, Rekkas S, Hebig P, Mishra G, Moldawer LL, Copeland EM, 3rd and Mackay S: Nuclear factor-kappa B is up-regulated in colorectal cancer. Surgery 130: 363-369, 2001.
24. Sinicrope FA: Targeting cyclooxygenase-2 for prevention and therapy of colorectal cancer. Mol Carcinog 45: 447-454, 2006.
25. Yan C, Jamaluddin MS, Aggarwal B, Myers J and Boyd DD: Gene expression profiling identifies activating transcription factor 3 as a novel contributor to the proapoptotic effect of curcumin. Mol Cancer Ther 4: 233-241, 2005.
26. Syed V, Mukherjee K, Lyons-Weiler J, Lau KM, Mashima T, Tsuruo T and Ho SM: Identification of ATF3, caveolin-1, DLC- 1, and NM23-H2 as putative antitumorigenic, progesteroneregulated genes for ovarian cancer cells by gene profiling. Oncogene 24: 1774-1787, 2005.
27. Bottone FG Jr., Martinez JM, Collins JB, Afshari CA and Eling TE: Gene modulation by the cyclooxygenase inhibitor, sulindac sulfide, in human colorectal carcinoma cells: Possible link to apoptosis. J Biol Chem 278: 25790-25801, 2003.
28. Yin X, Dewille JW and Hai T: A potential dichotomous role of ATF3, an adaptive-response gene, in cancer development. Oncogene 27: 2118-2127, 2008.
29. Kwok S, Rittling SR, Partridge NC, Benson CS, Thiyagaraj M, Srinivasan N and Selvamurugan N: Transforming growth factor- β1 regulation of ATF3 and identification of ATF3 target genes in breast cancer cells. J Cell Biochem 108: 408-414, 2009.
30. Turchi L, Aberdam E, Mazure N, Pouyssegur J, Deckert M, Kitajima S, Aberdam D and Virolle T: HIF-2α mediates UVinduced apoptosis through a novel ATF3-dependent death pathway. Cell Death Differ 15: 1472-1480, 2008.
31. Yang H, Choi HJ, Park SH, Kim JS and Moon Y: Macrophageinhibitory cytokine-1 MIC-1 and subsequent urokinase-type plasminogen activator mediate cell death responses by ribotoxic anisomycin in HCT-116 colon cancer cells. Biochem Pharmacol 78: 1205-1213, 2009.